{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:58:24Z","timestamp":1790837904835,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.mayocp.2025.11.003","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T04:55:50Z","timestamp":1770958550000},"page":"1751-1777","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Utility of Next-Generation Sequencing in Renal Neoplasia, Including Tumors With Clear Cytoplasm and Rare Phenotypes (ELOC\/MITF Alterations and Mismatch Repair Deficiency)"],"prefix":"10.1016","volume":"101","author":[{"given":"Michael","family":"McCarthy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonina A.","family":"Wojcik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily G.","family":"Barr Fritcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burak","family":"Tekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussam","family":"Al-Kateb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surendra","family":"Dasari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kingsley","family":"Ebare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan P.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa L.","family":"Stanton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Raghunathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rumeal D.","family":"Whaley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori A.","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loren Herrera","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael E.","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian A.","family":"Costello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Potretzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A.","family":"Boorjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley C.","family":"Leibovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Cheville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin R.","family":"Kipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5163-6955","authenticated-orcid":false,"given":"Sounak","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mayocp.2025.11.003_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2023.12.006","article-title":"Next generation sequencing-based identification of fusion-driven renal neoplasia: a single institution experience","volume":"152","author":"Tekin","year":"2024","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.mayocp.2025.11.003_bib2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/modpathol.2013.83","article-title":"Molecular cytogenetic analysis for TFE3 rearrangement in Xp11.2 renal cell carcinoma and alveolar soft part sarcoma: validation and clinical experience with 75 cases","volume":"27","author":"Hodge","year":"2014","journal-title":"Mod Pathol"},{"issue":"7","key":"10.1016\/j.mayocp.2025.11.003_bib3","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/modpathol.2017.24","article-title":"TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma: a distinct entity with potential implications for clinical management","volume":"30","author":"Gupta","year":"2017","journal-title":"Mod Pathol"},{"issue":"11","key":"10.1016\/j.mayocp.2025.11.003_bib4","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1097\/PAS.0000000000001307","article-title":"TFEB expression profiling in renal cell carcinomas: clinicopathologic correlations","volume":"43","author":"Gupta","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.mayocp.2025.11.003_bib5","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/ajcp\/aqad089","article-title":"Lessons from 801 clinical TFE3\/TFEB fluorescence in situ hybridization assays performed on renal cell carcinoma suspicious for MiTF family aberrations","volume":"160","author":"Wang","year":"2023","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.mayocp.2025.11.003_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2025.105797","article-title":"Evaluation of 3,606 renal cell tumors for TFE3 rearrangements and TFEB alterations via fluorescence in situ hybridization, next generation sequencing, and GPNMB immunohistochemistry","volume":"159","author":"Whaley","year":"2025","journal-title":"Hum Pathol"},{"issue":"11","key":"10.1016\/j.mayocp.2025.11.003_bib7","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1038\/modpathol.2012.107","article-title":"ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patients","volume":"25","author":"Sukov","year":"2012","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1016\/j.mayocp.2025.11.003_bib8","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1038\/s41379-020-0578-0","article-title":"ALK rearranged renal cell carcinoma (ALK-RCC): a multi-institutional study of twelve cases with identification of novel partner genes CLIP1, KIF5B and KIAA1217","volume":"33","author":"Kuroda","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.mayocp.2025.11.003_bib9","doi-asserted-by":"crossref","unstructured":"Arizpe D, Gallan AJ, Kase AM, Krishna M, Dasari S, Tekin B, Jimenez RE, Erickson LA, Cheville JC, Gupta S. ALK-Rearranged renal neoplasms: update on an institutional cohort. Virchows Arch. 2025 Oct 10. doi: 10.1007\/s00428-025-04292-2. Epub ahead of print. PMID: 41071329.","DOI":"10.1007\/s00428-025-04292-2"},{"issue":"12","key":"10.1016\/j.mayocp.2025.11.003_bib10","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.urolonc.2021.04.042","article-title":"A contemporary guide to chromosomal copy number profiling in the diagnosis of renal cell carcinoma","volume":"40","author":"Gupta","year":"2022","journal-title":"Urol Oncol"},{"key":"10.1016\/j.mayocp.2025.11.003_bib11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.humpath.2024.04.003","article-title":"Single nucleotide polymorphism (SNP) chromosomal microarray as a diagnostic tool for mucinous tubular and spindle cell carcinoma: a validation study","volume":"146","author":"Nielson","year":"2024","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.mayocp.2025.11.003_bib12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pathol.2020.10.002","article-title":"Clear cell papillary renal cell carcinoma: an update after 15 years","volume":"53","author":"Williamson","year":"2021","journal-title":"Pathology"},{"issue":"7456","key":"10.1016\/j.mayocp.2025.11.003_bib13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature12222","article-title":"Comprehensive molecular characterization of clear cell renal cell carcinoma","volume":"499","year":"2013","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.mayocp.2025.11.003_bib14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa1505917","article-title":"Comprehensive molecular characterization of papillary renal-cell carcinoma","volume":"374","author":"Linehan","year":"2016","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.mayocp.2025.11.003_bib15","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ccr.2014.07.014","article-title":"The somatic genomic landscape of chromophobe renal cell carcinoma","volume":"26","author":"Davis","year":"2014","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.mayocp.2025.11.003_bib16","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.celrep.2018.03.075","article-title":"The Cancer Genome Atlas comprehensive molecular characterization of renal cell carcinoma","volume":"23","author":"Ricketts","year":"2018","journal-title":"Cell Rep"},{"issue":"5","key":"10.1016\/j.mayocp.2025.11.003_bib17","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.eururo.2022.06.016","article-title":"The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs\u2013Part A: Renal, Penile, and Testicular Tumours","volume":"82","author":"Moch","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.mayocp.2025.11.003_bib18","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.humpath.2019.07.004","article-title":"Incidence of succinate dehydrogenase and fumarate hydratase-deficient renal cell carcinoma based on immunohistochemical screening with SDHA\/SDHB and FH\/2SC","volume":"91","author":"Gupta","year":"2019","journal-title":"Hum Pathol"},{"issue":"6","key":"10.1016\/j.mayocp.2025.11.003_bib19","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/modpathol.2008.44","article-title":"Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behavior","volume":"21","author":"Cheng","year":"2008","journal-title":"Mod Pathol"},{"issue":"7","key":"10.1016\/j.mayocp.2025.11.003_bib20","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/s41379-021-00779-w","article-title":"New developments in existing WHO entities and evolving molecular concepts: the Genitourinary Pathology Society (GUPS) update on renal neoplasia","volume":"34","author":"Trpkov","year":"2021","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.mayocp.2025.11.003_bib21","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/modpathol.2015.6","article-title":"TCEB1-mutated renal cell carcinoma: a distinct genomic and morphological subtype","volume":"28","author":"Hakimi","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.mayocp.2025.11.003_bib22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.humpath.2023.05.003","article-title":"Complex immunophenotypes: renal cell carcinoma with concurrent loss of SDHB\/INI1 and FH\/INI1","volume":"139","author":"Usatii","year":"2023","journal-title":"Hum Pathol"},{"key":"10.1016\/j.mayocp.2025.11.003_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2025.105813","article-title":"Morphologic and immunophenotypic characterization of conventional FLCN-mutated tumors (FMT) compared to a series of 8 non-conventional FMT","volume":"160","author":"Gupta","year":"2025","journal-title":"Hum Pathol"},{"issue":"11","key":"10.1016\/j.mayocp.2025.11.003_bib24","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1097\/PAS.0000000000002117","article-title":"Positive GPNMB immunostaining differentiates renal cell carcinoma with fibromyomatous stroma associated with TSC1\/2\/MTOR alterations from others","volume":"47","author":"Li","year":"2023","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.mayocp.2025.11.003_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2024.105680","article-title":"Metastatic renal cell carcinoma with fibromyomatous stroma associated with tuberous sclerosis or MTOR, TSC1\/TSC2-mutations: a series of 4 cases and a review of the literature","volume":"153","author":"Gupta","year":"2024","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.mayocp.2025.11.003_bib26","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.eururo.2025.03.012","article-title":"Renal neoplasia in Birt-Hogg-Dub\u00e9 syndrome: integrated histopathologic, bulk, and single-cell transcriptomic analysis","volume":"88","author":"Gupta","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.mayocp.2025.11.003_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2025.105799","article-title":"Unlocking diagnostic potential: a retrospective analysis of GPNMB immunohistochemistry in nearly 1000 surgical pathology specimens","volume":"159","author":"Li","year":"2025","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.mayocp.2025.11.003_bib28","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/path.5875","article-title":"GPNMB expression identifies TSC1\/2\/mTOR-associated and MiT family translocation-driven renal neoplasms","volume":"257","author":"Salles","year":"2022","journal-title":"J Pathol"},{"issue":"1, suppl","key":"10.1016\/j.mayocp.2025.11.003_bib29","first-page":"50","article-title":"Renal medullary carcinoma: a contemporary update","volume":"9","author":"Whaley","year":"2025","journal-title":"Kidney Cancer"},{"issue":"4","key":"10.1016\/j.mayocp.2025.11.003_bib30","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jmoldx.2025.01.002","article-title":"Clinical validation of the TruSight Oncology 500 assay for the detection and reporting of pan-cancer biomarkers","volume":"27","author":"Al-Kateb","year":"2025","journal-title":"J Mol Diagn"},{"issue":"7-8","key":"10.1016\/j.mayocp.2025.11.003_bib31","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cancergen.2012.06.005","article-title":"Molecular inversion probes: a novel microarray technology and its application in cancer research","volume":"205","author":"Wang","year":"2012","journal-title":"Cancer Genet"},{"issue":"8","key":"10.1016\/j.mayocp.2025.11.003_bib32","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/ng.2699","article-title":"Integrated molecular analysis of clear-cell renal cell carcinoma","volume":"45","author":"Sato","year":"2013","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.mayocp.2025.11.003_bib33","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.euf.2019.11.013","article-title":"Putative drivers of aggressiveness in TCEB1-mutant renal cell carcinoma: an emerging entity with variable clinical course","volume":"7","author":"DiNatale","year":"2021","journal-title":"Eur Urol Focus"},{"issue":"5413","key":"10.1016\/j.mayocp.2025.11.003_bib34","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1126\/science.284.5413.455","article-title":"Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function","volume":"284","author":"Stebbins","year":"1999","journal-title":"Science"},{"issue":"20","key":"10.1016\/j.mayocp.2025.11.003_bib35","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.1158\/1078-0432.CCR-20-4058","article-title":"Prevalence and landscape of actionable genomic alterations in renal cell carcinoma","volume":"27","author":"Attalla","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.mayocp.2025.11.003_bib37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/ng.3146","article-title":"Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes","volume":"47","author":"Durinck","year":"2015","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.mayocp.2025.11.003_bib38","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/his.13439","article-title":"Novel gene fusion of PRCC-MITF defines a new member of MiT family translocation renal cell carcinoma: clinicopathological analysis and detection of the gene fusion by RNA sequencing and FISH","volume":"72","author":"Xia","year":"2018","journal-title":"Histopathology"},{"issue":"7375","key":"10.1016\/j.mayocp.2025.11.003_bib39","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature10539","article-title":"A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma","volume":"480","author":"Bertolotto","year":"2011","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.mayocp.2025.11.003_bib36","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.32615","article-title":"Assessment of risk of hereditary predisposition in patients with melanoma and\/or mesothelioma and renal neoplasia","volume":"4","author":"Gupta","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.mayocp.2025.11.003_bib40","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.urology.2020.11.025","article-title":"Clinical and molecular characterization of microphthalmia-associated transcription factor (MITF)-related renal cell carcinoma","volume":"149","author":"Lang","year":"2021","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.mayocp.2025.11.003_bib41","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.path.2024.09.001","article-title":"Renal neoplasia: rare subtypes and uncommon clinical presentations","volume":"18","author":"Gupta","year":"2025","journal-title":"Surg Pathol Clin"},{"issue":"7","key":"10.1016\/j.mayocp.2025.11.003_bib42","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/his.14084","article-title":"Frequent KRAS mutations in oncocytic papillary renal neoplasm with inverted nuclei","volume":"76","author":"Tong","year":"2020","journal-title":"Histopathology"},{"issue":"7","key":"10.1016\/j.mayocp.2025.11.003_bib43","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/PAS.0000000000001467","article-title":"Biphasic hyalinizing psammomatous renal cell carcinoma (BHP RCC): a distinctive neoplasm associated with somatic NF2 mutations","volume":"44","author":"Argani","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.mayocp.2025.11.003_bib44","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/his.14731","article-title":"Merlin immunohistochemistry is useful in diagnosis of tumours within the spectrum of biphasic hyalinizing psammomatous renal cell carcinoma","volume":"81","author":"Collins","year":"2022","journal-title":"Histopathology"},{"key":"10.1016\/j.mayocp.2025.11.003_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2024.105693","article-title":"Genetic validation of a TSC2 immunohistochemistry assay in TSC\/mTOR-pathway altered renal tumors","volume":"154","author":"Akbari","year":"2024","journal-title":"Hum Pathol"},{"issue":"10","key":"10.1016\/j.mayocp.2025.11.003_bib46","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/modpathol.2011.93","article-title":"Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions","volume":"24","author":"Martignoni","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.mayocp.2025.11.003_bib47","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.humpath.2019.02.008","article-title":"Immunohistochemistry for TFE3 lacks specificity and sensitivity in the diagnosis of TFE3-rearranged neoplasms: a comparative, 2-laboratory study","volume":"87","author":"Sharain","year":"2019","journal-title":"Hum Pathol"},{"issue":"5","key":"10.1016\/j.mayocp.2025.11.003_bib48","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1535-6108(02)00071-5","article-title":"HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron","volume":"1","author":"Mandriota","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.mayocp.2025.11.003_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2025.105953","article-title":"Genitourinary mesenchymal neoplasms with tumor-defining genetic alterations: a clinicopathologic and molecular correlative study of 71 cases","volume":"166","author":"Chou","year":"2025","journal-title":"Hum Pathol"},{"issue":"9","key":"10.1016\/j.mayocp.2025.11.003_bib50","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/modpathol.2013.242","article-title":"DICER1 mutations in childhood cystic nephroma and its relationship to DICER1-renal sarcoma","volume":"27","author":"Doros","year":"2014","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.mayocp.2025.11.003_bib51","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.juro.2016.05.100","article-title":"Biomarkers for Wilms tumor: a systematic review","volume":"196","author":"Cone","year":"2016","journal-title":"J Urol"},{"issue":"27","key":"10.1016\/j.mayocp.2025.11.003_bib52","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1200\/JCO.2015.62.1888","article-title":"Advances in Wilms tumor treatment and biology: progress through international collaboration","volume":"33","author":"Dome","year":"2015","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.mayocp.2025.11.003_bib53","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/PAP.0000000000000337","article-title":"Renal cell carcinoma with fibromyomatous stroma\u2013the whole story","volume":"29","author":"Shah","year":"2022","journal-title":"Adv Anat Pathol"},{"issue":"5","key":"10.1016\/j.mayocp.2025.11.003_bib54","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/PAS.0000000000001422","article-title":"\"Renal cell carcinoma with leiomyomatous stroma\" harbor somatic mutations of TSC1, TSC2, MTOR, and\/or ELOC (TCEB1): clinicopathologic and molecular characterization of 18 sporadic tumors supports a distinct entity","volume":"44","author":"Shah","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.mayocp.2025.11.003_bib55","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.humpath.2022.07.022","article-title":"The expanding role of BAP1 in clear cell renal cell carcinoma","volume":"133","author":"Kapur","year":"2023","journal-title":"Hum Pathol"},{"issue":"7","key":"10.1016\/j.mayocp.2025.11.003_bib56","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/jnci\/djaf060","article-title":"Determinants of late metastases in renal cell carcinoma","volume":"117","author":"Kapur","year":"2025","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.mayocp.2025.11.003_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2024.100472","article-title":"High-grade, nonsarcomatoid chromophobe renal cell carcinoma: a series of 22 cases with novel molecular features on a subset","volume":"37","author":"Baraban","year":"2024","journal-title":"Mod Pathol"},{"key":"10.1016\/j.mayocp.2025.11.003_bib58","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.humpath.2021.11.003","article-title":"Differential immunohistochemical and molecular profiling of conventional and aggressive components of chromophobe renal cell carcinoma: pitfalls for diagnosis","volume":"119","author":"Chen","year":"2022","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.mayocp.2025.11.003_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100396","article-title":"Genetic profiling uncovers genome-wide loss of heterozygosity and provides insight into mechanisms of sarcomatoid transformation in chromophobe renal cell carcinoma","volume":"37","author":"Collins","year":"2024","journal-title":"Mod Pathol"},{"issue":"7","key":"10.1016\/j.mayocp.2025.11.003_bib60","doi-asserted-by":"crossref","first-page":"817","DOI":"10.5858\/arpa.2022-0127-OA","article-title":"Molecular and immunophenotypic correlates of metastatic epithelioid angiomyolipoma include alterations of TP53, RB1, and ATRX","volume":"147","author":"McCarthy","year":"2023","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.mayocp.2025.11.003_bib61","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.humpath.2023.10.001","article-title":"Molecular alterations in primary and metastatic PEComa: insights from the AACR project GENIE data set","volume":"143","author":"Gagnon","year":"2024","journal-title":"Hum Pathol"},{"key":"10.1016\/j.mayocp.2025.11.003_bib62","article-title":"Comprehensive genomic analysis of metastatic non-clear-cell renal cell carcinoma to identify therapeutic targets","volume":"3","author":"Carlo","year":"2019","journal-title":"JCO Precis Oncol"},{"issue":"3","key":"10.1016\/j.mayocp.2025.11.003_bib63","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41379-021-00918-3","article-title":"An unusual phenotype occurs in 15% of mismatch repair-deficient tumors and is associated with non-colorectal cancers and genetic syndromes","volume":"35","author":"Jaffrelot","year":"2022","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.mayocp.2025.11.003_bib64","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000443311","article-title":"The microphthalmia-associated transcription factor p.E318K mutation does not play a major role in sporadic renal cell tumors from Caucasian patients","volume":"83","author":"Stoehr","year":"2016","journal-title":"Pathobiology"},{"issue":"6","key":"10.1016\/j.mayocp.2025.11.003_bib65","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/s41379-021-00998-1","article-title":"Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 new tumors in 59 patients","volume":"35","author":"Fuchs","year":"2022","journal-title":"Mod Pathol"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619625006093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619625006093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:32:50Z","timestamp":1790836370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619625006093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":65,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0025619625006093"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2025.11.003","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utility of Next-Generation Sequencing in Renal Neoplasia, Including Tumors With Clear Cytoplasm and Rare Phenotypes (ELOC\/MITF Alterations and Mismatch Repair Deficiency)","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2025.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc on behalf of Mayo Foundation for Medical Education and Research.","name":"copyright","label":"Copyright"}]}}